Lonza Group Ltd (LONN)
Lonza Group Ltd supplies products and services to the pharmaceutical, biotech, and specialty ingredients markets worldwide.
If you are interested in LONN stock information, you might also be interested in competitors like LSE:JMAT.
With a P/E ratio of 15.00, the stock appears relatively expensive compared to its index ^SSMI at the moment.
The market capitalization of Lonza Group Ltd is currently at CHF45.98 B. This places it among the high capitalized companies.
The book value reported in the balance sheet results in a P/B ratio of 6.21.
With one share of Lonza Group Ltd investors achieved a dividend of CHF2.97. This results in a very low dividend yield of 0.49%. In the last 7 years, the annual dividend has risen constantly.
For the risk analysis, the low beta factor should be noted, which is currently at a value of 0.42. The price of the stock SWX:LONN is therefore subject to moderate fluctuations in relation to the overall market.
0.12% of LONN Stocks is owned by insiders.
For Wall Street analysts, a price target of CHF756.46 is currently considered realistic.
SWX:LONN has a 52 week range of CHF516.20 - CHF785.40 and is currently trading around CHF607.00.
The low short sale ratio indicated that the value might increase in the foreseeable future.